Related Experiment Video
Updated: Jul 30, 2026

13:36
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
10.5K
Understanding Post Entry Sorting of Adenovirus Capsids; A Chance to Change Vaccine Vector Properties
Coralie F Daussy1, Noémie Pied1, Harald Wodrich1
1Microbiologie Fondamentale et Pathogénicité, MFP CNRS UMR 5234, University of Bordeaux, 146 rue Leo Saignat, CEDEX, 33076 Bordeaux, France.
Viruses
|July 2, 2021
Summary
Adenovirus vectors are effective genetic vaccines for SARS-CoV-2. Understanding capsid properties, like protein VI mutations, can optimize viral vector design for improved vaccine efficacy.
Area of Science:
- Virology
- Vaccinology
- Molecular Biology
Background:
- Adenovirus vectors are a promising platform for genetic vaccines, particularly against SARS-CoV-2.
- Their immunogenicity, low pathogenicity, and technological ease make them attractive vaccine candidates.
- Research is exploring rare serotypes and non-human adenoviruses to enhance vector performance.
Purpose of the Study:
- To review the role of the adenovirus capsid in viral vector uptake and subcellular sorting.
- To explore how capsid properties influence immune responses.
- To discuss the impact of specific capsid protein mutations on vector behavior and vaccine development.
Main Methods:
- Review of existing literature on adenovirus vector biology and vaccine development.
- Analysis of capsid properties, including stability and protein interactions.
- Focus on the function of capsid protein VI in viral entry and intracellular trafficking.
Main Results:
- The choice of adenovirus serotype and capsid genotype significantly impacts particle uptake and subcellular localization.
- Capsid stability during entry is crucial for determining the fate of viral particles and subsequent immune outcomes.
- Mutations in capsid protein VI alter post-entry sorting mechanisms in species C adenoviruses.
Conclusions:
- Understanding adenovirus capsid properties is key to optimizing genetic vaccine vectors.
- Modifications to capsid proteins, such as protein VI, offer potential strategies for enhancing vaccine efficacy.
- These insights have broader implications for the development of advanced viral vector-based vaccines and therapeutics.
Keywords:
SARS-CoV-2adaptive immunityadenovirusautophagyinnate immunityintracellular traffickingvaccine vectorvirus entryMore Related Videos
Related Concept Videos
Viral Structure
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.

